How to buy stocks in Ligand Pharmaceuticals Incorporated
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LGND – and research it before...
Full Answer
When did Ligand Pharmaceuticals stock peak?
Ligand Pharmaceuticals’ stock price peaked in September 2018, when shares were trading at around $274 per share.
Where is LGND headquartered?
LGND Stock History. Ligand Pharmaceuticals is a biopharmaceutical company headquartered in San Diego, California. The company was introduced to the market as Progenx Inc. in 1987 and had its initial public offering in 1992.
What is stop loss order?
A stop-loss order is a type of sell order that protects you from volatile price dips. If you buy LGND at a price of $200 per share, you might set a stop-loss order to execute at $180. If the price of LGND drops to $180, your broker will automatically sell your shares.
What is market order?
A market order is a type of order that executes as soon as it is received by the broker in most circumstances. When you place a market order, you won’t specify a price that you need your order to be executed at. This is because your broker will execute the order at the current market price, no matter what it is, so long as your account is funded accordingly. Use a market buy when you need an order to be executed as quickly as possible.
What is a limit buy order?
A limit order is a type of order executed at a specific price point. For example, if you place a limit buy order to purchase 10 shares of LGND with a limit price of $180, your broker will execute the order only if it is possible to invest in LGND at a price of $180 or lower per share. If the price of LGND rises above a price of $180 per share, your broker will not execute your order. Use a limit order when you want to invest in a security only at a particular price point.
What is spread in stocks?
The spread is the difference between the bid price and the ask price. Stocks with a high daily trading volume typically have small spreads, while stocks without as much volatility or small stocks under $10 might have a larger spread. Monitoring the spread and how it’s changing can help you decide on the most advantageous time to buy.
What is Robinhood trading?
Robinhood is the broker for traders who want a simple, easy-to-understand layout without all the bells and whistles other brokers offer. Though its trading options and account types are limited, even an absolute beginner can quickly master Robinhood’s intuitive and streamlined platform. On the other hand, more advanced traders might be frustrated by Robinhood’s lack of technical analysis tools, a feature that’s now nearly universal across other platforms.
What is Ligand Pharmaceuticals?
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide . The company's commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for the treatment of osteoporosis; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of PPD; Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney, and other diseases. In addition, the company is involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated was founded in 1987 and is headquartered in San Diego, California.
How to calculate P/E ratio for Ligand Pharmaceuticals?
Ligand Pharmaceuticals Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3672. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
Is Ligand Pharmaceuticals a biotechnology company?
Ligand Pharmaceuticals Incorporated is a biotechnology business based in the US. Ligand Pharmaceuticals Incorporated stocks (LGND.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $115.39 – a decrease of 1.96% over the previous week. Ligand Pharmaceuticals Incorporated employs 155 staff and has a trailing 12-month revenue of around $208.4 million.
Ligand Pharmaceuticals Inc stock news
This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.
How to buy Ligand Pharmaceuticals Inc stock on Stash
1. Enter the amount you'd like to invest in Ligand Pharmaceuticals Inc stock, then proceed to checkout.
Invest in Ligand Pharmaceuticals Inc on Stash
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets.
What is Ligand Pharmaceuticals?
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide . The company's commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for the treatment of osteoporosis; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of PPD; Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney, and other diseases. In addition, the company is involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated was founded in 1987 and is headquartered in San Diego, California.
How to calculate P/E ratio for Ligand Pharmaceuticals?
Ligand Pharmaceuticals Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3067. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, February 23, 2022, and so far it has risen 6.38%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development.
Support, Risk & Stop-loss
Ligand Pharmaceuticals Incorporated finds support from accumulated volume at $98.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Ligand Pharmaceuticals Incorporated stock A Buy?
Ligand Pharmaceuticals Incorporated holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Insiders are negative selling more shares than they are buying in Ligand Pharmaceuticals Incorporated
In the last 100 trades there were 257.05 thousand shares bought and 366.24 thousand shares sold. The last trade was done 11 days ago by Korenberg Matthew E who sold 1.53 thousand shares. In general the insiders are selling more stocks than they buy.
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
